Biotricity, Inc. - Condensed Consolidated Statements of Cash Flows - USD ($)		3 Months Ended		6 Months Ended
		Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Cash flow from operating activities:
Net loss		$ (1,044,607)	$ (492,013)	$ (2,313,713)	$ (2,298,418)
Adjustments to reconcile net loss to net cash used in operations
Stock based compensation					1,297,586
Accretion expense	[1]	120,531		194,103
Change in fair value of derivative liabilities	[2]	123,268		742,227
Changes in operating assets and liabilities:
Harmonized sales tax recoverable				12,057	15,625
Accounts payable and accrued liabilities				214,851	50,721
Deposits and other receivables				26,117
Net Cash used in operating activities				(1,124,358)	(934,486)
Cash flows from financing activities:
Proceeds from exercise of warrants				13,000	470,758
Proceeds from issuance of convertible promissory notes				875,000
Due to shareholders				10,929
Net Cash provided by financing activities				898,929	470,758
Net decrease in cash during the period				(225,429)	(463,728)
Effect of foreign currency translation				(151,274)	51,367
Cash, beginning of period				410,601	448,599
Cash, end of period		$ 33,898	$ 36,238	$ 33,898	$ 36,238

[1] See Note 7

[2] See Note 8